Treatment of photodamaged skin: Use of meglumine and arginineto improve the texture of photodamaged skin

Cosmetic Dermatology

Volumn 21, Issue 9, 2008, Pages 495-498

  Kappler, Francis ^a   Zerweck, Charles R ^b   Grove, Gary L ^b   Tobia, Annette M ^a  

^a Dynamis Therapeutics Inc   (United States)

^b CyherDERM Clinical Studies   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349127479     PISSN: 10413766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Lutgers HL, Graaff R, Links TP, et al. Skin autofluorescence as a noninvasive marker of vascular damage in patients with type 2 diabetes. Diabetes Care. 2006;29:2654-2659. (Pubitemid 44912194)
2. Monami M, Lamanna C, Gori F, et al. Skin autofluorescence in type 2 diabetes: beyond blood glucose. Diabetes Res Clin Pract. 2008;79:56-60.
3. Monnier VM, Bautista O, Kenny D, et al. Skin collagen glycation, glycoxidation, and crosslinking are lower in subjects with longterm intensive versus conventional therapy of type 1 diabetes: relevance of glycated collagen products versus HbAlc as markers of diabetic complications. DCCT Skin Collagen Ancillary Study Group. Diabetes Control and Complications Trial. Diabetes. 1999;48:870-880. (Pubitemid 29153089)
4. Sell DR, Lane MA, Johnson WA, et al. Longevity and the genetic determination of collagen glycoxidation kinetics in mammalian senescence. Proc Natl Acad Sci USA. 1996;93:485-490. (Pubitemid 26038182)
5. Stamatas GN, Estanislao RB, Suero M, et al. Facial skin fluorescence as a marker of the skin's response to chronic environmental insults and its dependence on age. Br] Dermatol. 2006;154:125-132. (Pubitemid 43381331)
6. Lohwasser C, Neureiter D, Weigle B, et al. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol. 2006;126:291-299. (Pubitemid 43323163)
7. Molinari J, Ruszova E, Velebny V, et al. Effect of advanced glycation endproducts on gene expression profiles of human dermal fibroblasts. Biogerontology. 2008;9:177-182.
8. Niwa T. 3-Deoxyglucosone: metabolism, analysis, biological activity, and clinical implication. J Chromatogr B Biomed Sci Appl. 1999;731:23-36. (Pubitemid 29376410)
9. Kappler F, Schwartz ML, Su B, et al. DYN 12, a small molecule inhibitor of the enzyme amadorase, lowers plasma 3-deoxyglucosone levels in diabetic rats. Diabetes Technol Ther. 2001;3:609-616. (Pubitemid 34202919)
10. Munro BH, Visintainer MA, Page EB. Statistical Methods for Health Care Research. Philadelphia, PA; J.B. Lippincott Company; 1986.
11. Principles of Product Evaluation: Objective Sensory Methods; Monograph on Cosmetic Science. Dorset, England: International Federation of Societies of Cosmetic Chemists; Micelle Press; 1987.